Loncar Cancer Immunotherapy Etf Market Value

CNCR Etf  USD 16.45  0.65  4.11%   
Loncar Cancer's market value is the price at which a share of Loncar Cancer trades on a public exchange. It measures the collective expectations of Loncar Cancer Immunotherapy investors about its performance. Loncar Cancer is selling at 16.45 as of the 28th of March 2024; that is 4.11% increase since the beginning of the trading day. The etf's lowest day price was 15.77.
With this module, you can estimate the performance of a buy and hold strategy of Loncar Cancer Immunotherapy and determine expected loss or profit from investing in Loncar Cancer over a given investment horizon. Check out Loncar Cancer Correlation, Loncar Cancer Volatility and Loncar Cancer Alpha and Beta module to complement your research on Loncar Cancer.
Symbol

The market value of Loncar Cancer Immuno is measured differently than its book value, which is the value of Loncar that is recorded on the company's balance sheet. Investors also form their own opinion of Loncar Cancer's value that differs from its market value or its book value, called intrinsic value, which is Loncar Cancer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Loncar Cancer's market value can be influenced by many factors that don't directly affect Loncar Cancer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Loncar Cancer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Loncar Cancer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Loncar Cancer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Loncar Cancer 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Loncar Cancer's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Loncar Cancer.
0.00
07/02/2023
No Change 0.00  0.0 
In 8 months and 28 days
03/28/2024
0.00
If you would invest  0.00  in Loncar Cancer on July 2, 2023 and sell it all today you would earn a total of 0.00 from holding Loncar Cancer Immunotherapy or generate 0.0% return on investment in Loncar Cancer over 270 days. Loncar Cancer is related to or competes with IShares US. The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by th... More

Loncar Cancer Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Loncar Cancer's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Loncar Cancer Immunotherapy upside and downside potential and time the market with a certain degree of confidence.

Loncar Cancer Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Loncar Cancer's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Loncar Cancer's standard deviation. In reality, there are many statistical measures that can use Loncar Cancer historical prices to predict the future Loncar Cancer's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Loncar Cancer's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
13.9916.2418.49
Details
Intrinsic
Valuation
LowRealHigh
13.9516.2018.45
Details
Naive
Forecast
LowNextHigh
14.3716.6318.88
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
15.4716.0516.62
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Loncar Cancer. Your research has to be compared to or analyzed against Loncar Cancer's peers to derive any actionable benefits. When done correctly, Loncar Cancer's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Loncar Cancer Immuno.

Loncar Cancer Immuno Backtested Returns

Loncar Cancer appears to be not too volatile, given 3 months investment horizon. Loncar Cancer Immuno has Sharpe Ratio of 0.16, which conveys that the entity had a 0.16% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Loncar Cancer, which you can use to evaluate the volatility of the etf. Please exercise Loncar Cancer's Downside Deviation of 2.09, risk adjusted performance of 0.1095, and Mean Deviation of 1.82 to check out if our risk estimates are consistent with your expectations. The etf secures a Beta (Market Risk) of 2.38, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Loncar Cancer will likely underperform.

Auto-correlation

    
  -0.93  

Near perfect reversele predictability

Loncar Cancer Immunotherapy has near perfect reversele predictability. Overlapping area represents the amount of predictability between Loncar Cancer time series from 2nd of July 2023 to 14th of November 2023 and 14th of November 2023 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Loncar Cancer Immuno price movement. The serial correlation of -0.93 indicates that approximately 93.0% of current Loncar Cancer price fluctuation can be explain by its past prices.
Correlation Coefficient-0.93
Spearman Rank Test-0.92
Residual Average0.0
Price Variance4.63

Loncar Cancer Immuno lagged returns against current returns

Autocorrelation, which is Loncar Cancer etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Loncar Cancer's etf expected returns. We can calculate the autocorrelation of Loncar Cancer returns to help us make a trade decision. For example, suppose you find that Loncar Cancer has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Loncar Cancer regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Loncar Cancer etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Loncar Cancer etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Loncar Cancer etf over time.
   Current vs Lagged Prices   
       Timeline  

Loncar Cancer Lagged Returns

When evaluating Loncar Cancer's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Loncar Cancer etf have on its future price. Loncar Cancer autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Loncar Cancer autocorrelation shows the relationship between Loncar Cancer etf current value and its past values and can show if there is a momentum factor associated with investing in Loncar Cancer Immunotherapy.
   Regressed Prices   
       Timeline  

Pair Trading with Loncar Cancer

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Loncar Cancer position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Loncar Cancer will appreciate offsetting losses from the drop in the long position's value.

Moving together with Loncar Etf

  0.91XLV Health Care SelectPairCorr
  0.92VHT Vanguard Health CarePairCorr
  0.9XBI SPDR SP BiotechPairCorr
  0.88IHI IShares US MedicalPairCorr

Moving against Loncar Etf

  0.83BITI ProShares Trust -PairCorr
  0.47GREI Goldman Sachs FuturePairCorr
The ability to find closely correlated positions to Loncar Cancer could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Loncar Cancer when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Loncar Cancer - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Loncar Cancer Immunotherapy to buy it.
The correlation of Loncar Cancer is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Loncar Cancer moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Loncar Cancer Immuno moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Loncar Cancer can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Loncar Cancer Immuno is a strong investment it is important to analyze Loncar Cancer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Loncar Cancer's future performance. For an informed investment choice regarding Loncar Etf, refer to the following important reports:
Check out Loncar Cancer Correlation, Loncar Cancer Volatility and Loncar Cancer Alpha and Beta module to complement your research on Loncar Cancer.
Note that the Loncar Cancer Immuno information on this page should be used as a complementary analysis to other Loncar Cancer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Complementary Tools for Loncar Etf analysis

When running Loncar Cancer's price analysis, check to measure Loncar Cancer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Loncar Cancer is operating at the current time. Most of Loncar Cancer's value examination focuses on studying past and present price action to predict the probability of Loncar Cancer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Loncar Cancer's price. Additionally, you may evaluate how the addition of Loncar Cancer to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Loncar Cancer technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
A focus of Loncar Cancer technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Loncar Cancer trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...